ArticleFrontiers in psychology2022
China public emotion analysis under normalization of COVID-19 epidemic: Using Sina Weibo.
Article in Frontiers in psychology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Granularity paradox: how emotion taxonomies shape GPT-5's affective cognition and human-AI alignment.Frontiers in psychology · 2026Article
- Evaluation of emotion classification schemes in social media text: an annotation-based approach.BMC psychology · 2024Article
- Will the Relaxation of COVID-19 Control Measures Have an Impact on the Chinese Internet-Using Public? Social Media-Based Topic and Sentiment Analysis.International journal of public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prevention and control of the coronavirus disease 2019 (COVID-19) epidemic in China has entered a phase of normalization. The basis for evaluating and improving public health strategies is understanding the emotions and concerns of the public. This study establishes a fine-grained emotion-classification model to annotate the emotions of 32,698 Sina Weibo posts related to COVID-19 prevention and control from July 2022 to August 2022. The Dalian University of Technology (DLUT) emotion-classification system was adjusted to form four pairs (eight categories) of bidirectional emotions: good-disgust, joy-sadness, anger-fear, and surprise-anticipation. A lexicon-based method was proposed to classify the emotions of Weibo posts. Based on the selected Weibo posts, the present study analyzed the Chinese public's sentiments and emotions. The results showed that positive sentiment accounted for 51%, negative sentiment accounted for 24%, and neutral sentiment accounted for 25%. Positive sentiments were dominated by good and joy emotions, and negative sentiments were dominated by fear and disgust emotions. The proportion of positive sentiments on official Weibo (accounts belonging to government departments and official media) is significantly higher than that on personal Weibo. Official Weibo users displayed a weak guiding effect on personal users in terms of positive sentiment and the two groups of users were almost completely synchronized in terms of negative sentiment. The linear discriminant analysis (LDA) was performed on the two negative emotions of fear and disgust in the personal posts. The present study found that the emotion of fear was mainly related to COVID-19 infection and death, control of people with positive nucleic acid tests, and the outbreak of local epidemic, while the emotion of disgust was mainly related to the long-term existence of the epidemic, the cost of nucleic acid tests, non-implementation of prevention and control measures, and the occurrence of foreign epidemics. These findings suggest that Chinese attitudes toward epidemic prevention and control are positive and optimistic; however, there is also a notable proportion of fear and disgust. It is expected that this study will help public health administrators to evaluate the effectiveness of possible countermeasures and work toward precise prevention and control of the COVID-19 epidemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.